Prenetics Global Ltd. has reaffirmed its full-year 2025 revenue guidance, projecting total revenues of $90 to $100 million. The company expects its IM8 business unit to contribute $60 million in revenue for the year. For the fourth quarter of 2025, Prenetics has provided revenue guidance of $28 million for IM8, representing a 63% increase quarter-over-quarter compared to the third quarter of 2025. Looking ahead to 2026, IM8's full-year revenue is expected to reach between $180 and $200 million, with a target of approximately $25 million in monthly revenue or $300 million in annual recurring revenue $(ARR)$ by the end of 2026. This outlook follows a significant surge in business performance, as Prenetics reported a 567.7% year-over-year increase in total revenue to $23.6 million for the third quarter of 2025, and a 631.2% rise in gross profit to $14.0 million over the same period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prenetics Global Ltd. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.
Comments